PFS longer in pancreatic ductal adenocarcinoma with versus without homologous recombination deficiency
Post-approval study results on the risk of hyperinflation, acute pancreatitis, and death associated with the use of liquid-filled intragastric balloons have been made available by the FDA.
Mild pancreatic injury patterns were observed in a group of patients who were diagnosed with COVID-19 pneumonia, according to results published in Gastroenterology.
There are significant differences in the clinical features of early, late, and alcohol-related idiopathic chronic pancreatitis.
A team of investigators from China sought to assess the effect of sedation with intravenous lidocaine during endoscopic retrograde cholangiopancreatography (ERCP).
Receipt of molecularly matched therapy is associated with improved outcomes in patients with pancreatic cancer.
In the management of PNETs it is important to differentiate between functional and nonfunctional PNETs in order to determine the course of treatment.
A novel dual-hormone artificial pancreas system that delivers both rapid insulin and pramlintide was found to improve glucose control.
Natural genetic variants in a calcium-selective ion channel gene, TRPV6, appear to influence early-onset chronic pancreatitis.
Results of this study showed no improvement in the rate of 30-day hospital readmission for patients with cancer undergoing pancreatectomy between 2005 and 2011.
Chronic pancreatitis is associated with increased risk for diabetes-associated emergencies, including diabetic ketoacidosis.
The Food and Drug Administration has approved a new formulation of Pancreaze (pancrelipase; Vivus) Delayed Release Capsules which would allow for an extended shelf life of 36 months.
Promising results from an earlier-phase study of FOLFOX plus pegilodecakin in metastatic PDAC refractory to gemcitabine provided a rationale for this study.
Exceeding tolerances of healthy organs-at-risk as a result of daily anatomical deformations is a concern for patients with LAPC treated with SBRT.
The Food and Drug Administration (FDA) has approved Dayvigo (lemborexant; Eisai) for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adult patients.
A study of an Asian population failed to find a link between the virus and malignancies outside of the liver.
Patients who had tumors measuring 1.5 cm to 2 cm were at double the risk for lymph node metastasis.
Research presented at SITC 2019 looks at 2 different mechanisms for resistance to immune checkpoint inhibition in pancreatic ductal adenocarcinoma.
Pain phenotypes can be used in the future to attempt prediction of response to treatment in patients with painful chronic pancreatitis and thus provides a framework for personalized pain management.
Although higher nurse-to-patient ratios ensure good outcomes for patients undergoing pancreaticoduodenectomy, PD-specific surgeon volume has a greater effect on risks of complications for these patients.